Specifically, researchers examined the effects of intra-articular injections of AOD9604, both alone and in combination with HA, on cartilage morphology, histopathology, and functional outcomes such as lameness
AOD 9604 will only specifically act on fat metabolism, thereby possibly allowing safer and more specific long-term administration and situation unlike in various other weight loss medications, since a variety of other foci are involved
Also, subcutaneous delivery is safe and easy to self-administer
No fluid retention worth noting
In-vitro assays show the molecule is membrane-permeable, which supports the possibility of oral absorption, but the animal efficacy studies used injection, and no study has directly compared oral versus subcutaneous bioavailability
TPM holds promise for a more effective and targeted use of AOD-9604 in combating cellulite and subcutaneous fat, marking an exciting turn in the journey of this unique molecule